Introduction: Obesity is a complex disorder that involves some degree of over-consumption¹ coupled with a metabolic derangement. As ADA has been putatively associated with inflammation, and adipose tissue inflammation is the hallmark of insulin resistance in obese T2DM patients. Our study attempted to evaluate the role of serum ADA in T2DM subjects.

Methods: This observational cross sectional study was conducted in the Department of Biochemistry at MGM Medical College and MY Hospital. All the patients and controls were clinically examined and routine biochemical tests were analyzed for all subjects.

Result: Correlations of ADA with different predictors of obesity and diabetes were calculated. ADA was found to be positively correlated with FBS, HBA1C, Insulin, Leptin and HOMA IR whereas negative correlation was found between ADA and Adiponectin.

Conclusion: This is very much evident through this study that ADA may be treated as prognostic predictor of diabetes either linked to obesity or not.

Keywords: ADA; Diabetes; Obesity.

1. Amatruda JM, Statt MC, Welle SL. (1993). Total and resting energy expenditure in obese women reduced to ideal body weight. J Clin Invest, 92:1236–42.
2. Flier JS. (1995). The adipocytes: storage depot or node on the energy information superhighway? Cell 80: 15–18.
3. Dhingra V, Chatterjee A, Guleria R, Sharma R, Pandey RM, Talwar KK, Misra A. (2002). Adverse physical activity pattern in urban adolescents (Abstract). J Assoc Physicians India 50:1521. A, Greten TF, Sinha B, Haslberger C, Sullivan GW, Endres S. (1997)
4. Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. (1998). Prevalenceof type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol 66:65–72.
5. Wild S, Roglic G, Green A, Sicree R, King H. (2004). Global prevalenceof diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–53.
6. Spencer N, Hopkinson D, Harris H. (1968). Adenosine deaminase polymer-phism in man. Ann Hum Genet 32:9–14.
7. Bottini E, Gloria-Bottini F. (1999). Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism 48:949–51.
8. Rebecca Kanter2,3 and Benjamin Caballerodoi: 10.3945/​an.112.002063 Adv Nutr (July 2012) AdvNutr vol. 3: 491-498, 201
9. Kim I-H, Chun H, Kwon J-W. Gender Differences in the Effect of Obesity on Chronic Diseases among the Elderly Koreans. Journal of Korean Medical Science. 2011;26(2):250-257. doi:10.3346/jkms.2011.26.2.250.
10. Wei, M., Gaskill, S. P., Haffner, S. M. and Stern, M. P. (1997), Waist Circumference as the Best Predictor of Noninsulin Dependent Diabetes Mellitus (NIDDM) Compared to Body Mass Index, Waist/hip Ratio and Other Anthropometric Measurements in Mexican Americans—A 7-Year Prospective Study. Obesity Research, 5: 16–23. doi:10.1002/j.1550-8528.1997.tb00278.xAshish Anantrao Jadhav and Anuradha (Jain 2012)
11. Green A. (1987). Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist. J Biol Chem 262:15702–7.
12. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. (1995).The expression of tumour necrosis factor in human adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111–19.
13. Firestein GS, Boyle D, Bullough DA, Gruber HE, Sajjadi FG, Montag A, Sambol B, Mullane KM. (1994). Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol 152:5853–9.
14. Adanin S, Yalovetskiy IV, Nardulli BA, Sam II AD, Jonjev ZS, Law WR.(2002). Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis. Am J Physiol RegulIntegr Comp Physiol 282:R1324–32
15. Mohan V. (2004). Why are Indians more prone to diabetes? J Assoc Physicians India 52:468–74.
16. Cronstein BN, Eberle MA, Gruber HE, Levin RI. (1991). Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. ProcNatlAcadSci USA 88:2441–5.
17. Cronstein BN, Montesinos MC, Weiss-mann G. (1999). Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB. Proc Natl Acad Sci USA 96:6377–81.
18. Cronstein BN, Naime D, Firestein GS. (1995). The anti-inflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 38:1040–45.
19. Gadangi P, Longaker M, Naime D, Levin RI, Recht PA, Montesinos MC,Buckley MT, Carlin G, Cronstein BN. (1996). The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol 156:1937–41.

Dr Neeraj Gour

Associate Professor, Dept of Community Medicine,

SHKM Govt Medical College, Nuh, Haryana

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile:  08199997935